Arcutis Biotherapeutics | ARS: Annual Report to Security Holders
Apr 26 22:19 ET
Arcutis Biotherapeutics | DEFA14A: Others
Apr 26 16:40 ET
Arcutis Biotherapeutics | DEF 14A: Definitive information statements
Apr 26 16:39 ET
Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Topper David Joseph
Apr 11 20:36 ET
Arcutis Biotherapeutics | 3: Initial statement of beneficial ownership of securities-Officer Topper David Joseph
Apr 11 20:36 ET
Arcutis Biotherapeutics | 8-K: Current report
Apr 10 16:19 ET
Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Matsuda Masaru
Mar 6 17:20 ET
Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burnett Patrick
Mar 6 17:16 ET
Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Watanabe Todd Franklin
Mar 6 17:15 ET
Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Moore Matthew Richard
Mar 6 17:11 ET
Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Heron Patrick J
Mar 6 16:31 ET
Arcutis Biotherapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Frazier Life Sciences VIII, L.P.(7.8%),FHM Life Sciences VIII, L.P.(7.8%), etc.
Mar 6 12:44 ET
Arcutis Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jennison Associates LLC(10.8%)
Mar 6 10:33 ET
Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 4 17:54 ET
Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 4 17:47 ET
Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 4 17:47 ET
Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 4 17:45 ET
Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 4 17:43 ET
Arcutis Biotherapeutics | 8-K: Current report
Mar 4 16:11 ET
Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Watanabe Todd Franklin
Mar 1 16:17 ET
No Data
No Data